Bydureon 2MG Vial + Syringe


Indications and Reactions:

Role Indications Reactions
Primary
Type 2 Diabetes Mellitus 70.4%
Insulin-requiring Type 2 Diabetes Mellitus 14.2%
Diabetes Mellitus 3.7%
Hypertension 2.1%
Gastrooesophageal Reflux Disease 1.0%
Blood Cholesterol Increased 0.9%
Constipation 0.9%
Cardiac Disorder 0.7%
Injection Site Pruritus 0.7%
Pruritus 0.7%
Fluid Retention 0.6%
Injection Site Haemorrhage 0.6%
Thyroid Disorder 0.6%
Affective Disorder 0.4%
Hypothyroidism 0.4%
Injection Site Pain 0.4%
Muscle Spasms 0.4%
Prophylaxis 0.4%
Urticaria 0.4%
Weight Decreased 0.4%
Weight Decreased 16.7%
Injection Site Nodule 15.3%
Injection Site Haemorrhage 12.5%
Off Label Use 11.0%
Injection Site Pruritus 8.2%
Injection Site Pain 7.8%
Underdose 4.6%
Nausea 3.9%
Vomiting 3.9%
Blood Glucose Increased 3.6%
Weight Increased 2.8%
Injection Site Mass 1.8%
Urticaria 1.4%
Diarrhoea 1.1%
Flatulence 1.1%
Intentional Drug Misuse 1.1%
Pain 1.1%
Drug Ineffective 0.7%
Eructation 0.7%
Increased Appetite 0.7%
Secondary
Type 2 Diabetes Mellitus 84.6%
Diabetes Mellitus 5.1%
Fluid Retention 5.1%
Back Pain 1.3%
Injection Site Haemorrhage 1.3%
Insulin-requiring Type 2 Diabetes Mellitus 1.3%
Pain In Extremity 1.3%
Weight Decreased 40.9%
Injection Site Mass 9.1%
Injection Site Nodule 4.5%
Injection Site Pruritus 4.5%
Lipase Increased 4.5%
Nausea 4.5%
Nervousness 4.5%
Off Label Use 4.5%
Overdose 4.5%
Pain 4.5%
Sinusitis 4.5%
Skin Reaction 4.5%
Weight Increased 4.5%

Drug Data